Altimmune Inc (ALT)
4.765
+0.02
(+0.42%)
USD |
NASDAQ |
Apr 02, 16:00
4.65
-0.12
(-2.41%)
After-Hours: 20:00
Altimmune Total Liabilities (Quarterly): 15.80M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Viking Therapeutics Inc | 28.04M |
| Eli Lilly and Co | 64.44B |
| Amgen Inc | 85.96B |
| Terns Pharmaceuticals Inc | 18.06M |
| Pfizer Inc | 124.90B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 139.31M |
| Shareholders Equity (Quarterly) | 123.51M |
| Current Ratio | 13.11 |